NDC 68180-423 – Cefixime
Cefixime 400 mg/1 · Capsule · Oral
Product NDC68180-423
Product details
- Brand name
- Cefixime
- Generic name
- Cefixime
- Labeler
- Lupin Pharmaceuticals, Inc.
- Dosage form
- Capsule
- Route
- Oral
- Marketing category
- NDA AUTHORIZED GENERIC · NDA203195
- Marketed since
- October 14, 2020
- Listing expires
- December 31, 2026
- Pharmacologic class
- Cephalosporin Antibacterial
Active ingredients
- Cefixime 400 mg/1
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 68180-423-08 | 50 CAPSULE in 1 BOTTLE (68180-423-08) | Oct 14, 2020 |
| 68180-423-11 | 1 BLISTER PACK in 1 CARTON (68180-423-11) / 10 CAPSULE in 1 BLISTER PACK | Oct 14, 2020 |
Recalls mentioning this NDC
- D-0648-2024 Sep 4, 2024 · Class II
Subpotent Drug- An out of specification ( OOS ) result observed in assay test during 18-month long term stability study. - D-0559-2024 Jun 26, 2024 · Class II
Failed Content Uniformity Specifications - D-0274-2024 Feb 7, 2024 · Class II
Failed Impurities/Degradation Specifications - D-0390-2021 May 26, 2021 · Class II
Subpotent Drug - D-1252-2020 Apr 29, 2020 · Class II
Subpotent Drug: low out of specification (OOS) test result observed in long term stability study.
Other Cefixime products
- 67877-584 Cefixime 400 mg/1 · Capsule · Ascend Laboratories, LLC
- 59651-647 Cefixime 400 mg/1 · Capsule · Aurobindo Pharma Limited
- 65862-751 Cefixime 100 mg/5mL · Powder, For Suspension · Aurobindo Pharma Limited
- 65862-752 Cefixime 200 mg/5mL · Powder, For Suspension · Aurobindo Pharma Limited
- 68180-405 Cefixime 100 mg/5mL · Powder, For Suspension · Lupin Pharmaceuticals, Inc.
- 68180-407 Cefixime 200 mg/5mL · Powder, For Suspension · Lupin Pharmaceuticals, Inc.
- 70518-2749 Cefixime 400 mg/1 · Capsule · REMEDYREPACK INC.
- 70518-3221 Cefixime 400 mg/1 · Capsule · REMEDYREPACK INC.
- 70518-4759 Cefixime 400 mg/1 · Capsule · REMEDYREPACK INC.
- 64980-430 Cefixime 400 mg/1 · Tablet · Rising Pharma Holdings, Inc.